Tcrcure Biopharma Ltd.
Clinical trials sponsored by Tcrcure Biopharma Ltd., explained in plain language.
-
Engineered immune cells take aim at Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new treatment called Enhanced ALPP CAR-T cells for people with advanced solid tumors that have not responded to standard therapies. The treatment involves taking a patient's own immune cells, modifying them in a lab to recognize and attack cancer cells that hav…
Phase: EARLY_PHASE1 • Sponsor: TCRCure Biopharma Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New immune cell therapy takes on tough lung cancer
Disease control Recruiting nowThis early-stage trial is testing a new treatment called TC-D101 CAR-T for people with a specific type of advanced small cell lung cancer that has stopped responding to standard treatments. The therapy uses a patient's own immune cells, modified to target cancer cells, and is giv…
Phase: EARLY_PHASE1 • Sponsor: TCRCure Biopharma Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC